Autori: MacDonald D
| Naslov | Comparison of Subcutaneous and Intravenous Rituximab in the Maintenance Setting: Updated Safety Results of the Phase III Sabrina Study in Patients with Follicular Lymphoma (Meeting Abstract) |
| Autori | Davies A Mihaljevic Biljana S  Mercadal Santiago Mihaylov G Leppa S Cotting D Munoz FJ Veenstra K Berthillon N Barrett M MacDonald D
|
| Info | HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 1, str. 271-272 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Subcutaneous Rituximab and Chemotherapy Achieves Similar Overall Response Rates to Intravenous Rituximab in First-Line Follicular Lymphoma: Efficacy and Safety Results of the Phase Iii Sabrina Study (Meeting Abstract) |
| Autori | Davies A Merli Francesco Mihaljevic Biljana S Mercadal Santiago Solal-Celigny Philippe Boehnke Axel Berge Claude Cambon N Macgregor L Brewster M Barrett M MacDonald D
|
| Info | HAEMATOLOGICA, (2014), vol. 99 br. , Suppl. 1, str. 225-225 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicular lymphoma (FL) in the first-line setting: Stage 1 results of the phase III SABRINA study (Meeting Abstract) |
| Autori | Davies AJ Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett M MacDonald D
|
| Info | BRITISH JOURNAL OF HAEMATOLOGY, (2013), vol. 161 br. , Suppl. 1, str. 7-8 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
